Conference Coverage
Conference Coverage
Nail psoriasis therapies lack supporting evidence
An unmet need exists for a reliable nail psoriasis scoring system in order to improve the state of evidence-based treatment for this common...
Conference Coverage
Celiac disease ‘as common as psoriasis’
Dr. John J. Zone first began to study gluten sensitivity in 1977, an interest that left some of his clinician colleagues wondering why.
Conference Coverage
Simple screening tool can help detect psoriatic arthritis
Dr. Philip Mease provides an update on treatments for psoriatic arthritis.
Conference Coverage
Biologic treatment for psoriasis found to have CVD benefits
Evidence is mounting that the use of biologic therapies is associated with certain cardiovascular benefits in patients with psoriasis.
Conference Coverage
A call to action on metabolic syndrome and pediatric psoriasis
Conference Coverage
WCD: Touch avoidance is a new dimension of psoriatic impairment
Touch avoidance among psoriasis patients is an important new patient-reported outcome having a major negative quality-of-life impact.
Conference Coverage
EULAR’s psoriatic arthritis recommendations gain new drugs
Conference Coverage
WCD: Secukinumab shows effectiveness for nail, palmoplantar psoriasis
Key clinical point: Two phase IIIb trials show secukinumab at 300 mg is the most effective drug ever formally studied for nail or palmoplantar...
Conference Coverage
WCD: IL-23p19 inhibitors yield ‘promising’ psoriasis results
Conference Coverage
WCD: Ixekizumab beats etanercept for psoriatic itch
Key clinical point: Ixekizumab reduces psoriatic itch markedly faster and more profoundly than etanercept. Major finding: Psoriasis patients...